Steven Cohen Repare Therapeutics Inc. Transaction History

Point72 Asset Management, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$8.16 - $13.01 $997,968 - $1.59 Million	122,300 New	122,300 $1.48 Million
Q1 2022 May 16, 2022	SELL	$11.38 - $21.88 $324,330 - $623,580	-28,500 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$19.66 - $28.11 $613,352 - $876,975	-31,198 Reduced 52.26%	28,500 $601,000
Q3 2021 Nov 15, 2021	BUY	$25.71 - $35.24 $1.53 Million - $2.1 Million	59,698 New	59,698 $1.57 Million
Q2 2021 Aug 16, 2021	SELL	$30.1 - $34.85 $3.01 Million - $3.49 Million	-100,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$25.89 - $44.46 $5.24 Million - $9.01 Million	-202,584 Reduced 66.95%	100,000 $3.07 Million
Q4 2020 Feb 16, 2021	BUY	$23.42 - $39.5 $7.09 Million - $12 Million	302,584 New	302,584 $10.4 Million
Q3 2020 Nov 16, 2020	SELL	$21.55 - $33.92 $323,250 - $508,800	-15,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.8 - $32.99 $462,000 - $494,850	15,000 New	15,000 $465,000

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $56.6M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.